newsfilter
← Latest News
GlobeNewswire·

Aligos Therapeutics to Present at Upcoming Investor Conferences

  • Aligos Therapeutics, Inc. (NASDAQ: ALGS) announced that management will present at two upcoming investor conferences.
  • The company will participate in a fireside chat at the Jefferies London Healthcare Conference on Monday, November 17, 2025, at 3:00pm GMT.
  • Aligos will also present at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 2:00pm ET.
  • Presentations will be accessible via the "Investors" page on the company's website, with replays available for at least 30 days.
  • Aligos is a clinical-stage biopharmaceutical company developing therapies for liver diseases, viral diseases, chronic hepatitis B, obesity, MASH, and coronaviruses.
  • The press release includes forward-looking statements subject to risks related to drug development, clinical trials, regulatory approval, capital resources, and market conditions.